Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Acquisition of Schering AG Should Boost Profitability: Bayer Yakuhin
July 31, 2006
- Novo Nordisk Pharma to Cover GP Market in Future
July 31, 2006
- 3rd Science and Technology Forum
July 31, 2006
- Chugai to Market Modified Version of Tamiflu in Japan
July 31, 2006
- World's 1st Transdermal Agent for AD under Development by Novartis
July 31, 2006
- Anti-Parkinson's Drug KW-6002 Expected to Become Major Product: Kyowa Hakko
July 31, 2006
- SELF-MEDICATION NEWS IN BRIEF
July 31, 2006
- Covance Dedicates Itself to Development Service
July 31, 2006
- Astellas to Promote Vesicare as 1st Choice OAB Treatment
July 24, 2006
- SUEVEY
July 24, 2006
- Teijin Pharma to Focus on New Drug Development in the US, Europe
July 24, 2006
- PII Study on Implanted Cardiac Assist Device Initiated
July 24, 2006
- Torrent Seeks Alliances with Japanese Companies
July 24, 2006
- Annual NHI Price Revision Would Cause Confusion: Mr Henmi of Nichibyokyo
July 24, 2006
- Sysmex America Receives Premier Pinnacle Award
July 24, 2006
- Chuikyo Discusses Frequency of NHI Drug Price Revisions
July 24, 2006
- SEMINAR
July 24, 2006
- Basic Policies 2006 Call For Enhancement of Drug Industry's Int'l Competitiveness
July 24, 2006
- SELF-MEDICATION NEWS IN BRIEF
July 24, 2006
- NEW PRODUCTS
July 24, 2006
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…